| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.0008 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |